Clinical practice patterns for upper tract urothelial carcinoma: a nationwide survey in Japan

被引:18
|
作者
Kikuchi, Eiji [1 ]
Oya, Mototsugu [1 ]
机构
[1] Keio Univ, Sch Med, Dept Urol, Tokyo, Japan
关键词
clinical management; nationwide survey; renal pelvic tumor; upper tract urothelial carcinoma; ureteral tumor; UPPER URINARY-TRACT; NEOADJUVANT CHEMOTHERAPY; NEPHROURETERECTOMY; ASSOCIATION; CARBOPLATIN; PREVENTION; GUIDELINES; ADJUVANT; TUMORS; TRIAL;
D O I
10.1093/jjco/hyw072
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: A comprehensive survey has not yet been conducted to investigate care patterns by urologists for the management of upper tract urothelial carcinoma. Methods: We conducted a nationwide survey for urologists treating upper tract urothelial carcinoma patients. The questionnaire was approved by the Japanese Urological Association and sent by mail in February 2014 to 1119 institutes in Japan. We identified 627 responders for this study. Results: Our survey demonstrated that ( i) the mean number of radical nephroureterectomy cases per institution in 2013 was 7.6, ( ii) the main detecting tool for upper tract urothelial carcinoma is contrast-enhanced computed tomography, ( iii) the need for ureteroscopic evaluations is highly dependent on voiding urine cytology results, ( iv) 67% of urologists always or often perform radical nephroureterectomy by laparoscopic surgery, ( v) more than half of the urologists do not aggressively perform lymph node dissection, ( vi) 75% of the urologists perform bladder cuff incision through an extravesical approach, ( vii) urologists perform kidney-sparing surgery following various indications, ( viii) 59% of the urologists always perform adjuvant systemic chemotherapy for high-risk upper tract urothelial carcinoma patients, ( ix) the combination of gemcitabine and cisplatin is the most frequent chemo-regimen for metastatic upper tract urothelial carcinoma, and gemcitabine and cisplatin with dose reductions is also the first choice even in patients with impaired renal function and ( x) 10.5% of urologists always or sometimes perform single intravesical chemotherapy immediately after radical nephroureterectomy. Conclusions: The management strategy for upper tract urothelial carcinoma has changed with the introduction of new devices and development of instruments. The lack of clear evidence for relatively uncommon upper tract urothelial carcinoma affects the consistency of its treatment strategies.
引用
下载
收藏
页码:768 / 774
页数:7
相关论文
共 50 条
  • [41] Treatment of upper urinary tract urothelial carcinoma
    Cai, Guiyang
    Liu, Xuefeng
    Wu, Bin
    SURGICAL ONCOLOGY-OXFORD, 2011, 20 (01): : 43 - 55
  • [42] Endoscopic Treatment of Upper Tract Urothelial Carcinoma
    Daniel P. Verges
    Costas D. Lallas
    Scott G. Hubosky
    Demetrius H. Bagley
    Current Urology Reports, 2017, 18
  • [43] Upper Tract Urothelial Carcinoma: Special Considerations
    Hutchinson, Ryan
    Haddad, Ahmed
    Sagalowsky, Arthur
    Margulis, Vitaly
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (02) : 101 - 109
  • [44] Comparison of Genomic Characterization in Upper Tract Urothelial Carcinoma and Urothelial Carcinoma of the Bladder
    Yang, Kaiwei
    Yu, Wei
    Liu, Huanhuan
    Ding, Feng
    Zhang, Yanrui
    Zhang, Yun
    Wang, Wang
    Lou, Feng
    Cao, Shanbo
    Wang, Huina
    He, Zhisong
    ONCOLOGIST, 2021, 26 (08): : E1395 - E1405
  • [45] Metastatic urothelial carcinoma of upper urinary tract
    Li, Shau-Hsuan
    Huang, Wan-Ting
    Kuo, Ching-Yuan
    AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (10) : 940 - 941
  • [46] Diagnosis and management of upper tract urothelial carcinoma
    Krabbe, L. -M.
    Bagrodia, A.
    Westerman, M. E.
    Margulis, V.
    MINERVA UROLOGICA E NEFROLOGICA, 2014, 66 (01) : 37 - 48
  • [47] TARGETED SEQUENCING OF UPPER TRACT UROTHELIAL CARCINOMA
    Sfakianos, John P.
    Kim, Philip H.
    Iyer, Gopa
    Cha, Eugene K.
    Zabor, Emily C.
    Hakimi, A. A.
    Scott, Sasinya N.
    Ramirez, Ricardo
    Hanrahan, Aphrothiti J.
    Rosenberg, Jonathan E.
    Al-Ahmadie, Hikmat
    Ren, Qinghu
    Dalbagni, Guido
    Bajorin, Dean F.
    Berger, Michael F.
    Bochner, Bernard H.
    Solit, David B.
    Coleman, Jonathan A.
    JOURNAL OF UROLOGY, 2014, 191 (04): : E911 - E911
  • [48] An audit of nephroureterectomy for upper tract urothelial carcinoma
    Huang, C. -Y.
    Chung, S. -D.
    Wang, S. -M.
    Liao, C. -H.
    Lai, M. -K.
    Huang, K. -H.
    Pu, Y. -S.
    Chueh, S. -C.
    Yu, H. -J.
    EJSO, 2009, 35 (12): : 1333 - 1336
  • [49] The Role of Chemotherapy in Upper Tract Urothelial Carcinoma
    O'Donnell, Peter H.
    Stadler, Walter M.
    ADVANCES IN UROLOGY, 2009, 2009
  • [50] Endoscopic Treatment of Upper Tract Urothelial Carcinoma
    Verges, Daniel P.
    Lallas, Costas D.
    Hubosky, Scott G.
    Bagley, Demetrius H., Jr.
    CURRENT UROLOGY REPORTS, 2017, 18 (04)